Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03289039
Title Neratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast Cancer
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Indiana University Indianapolis Indiana 46202 United States Details
Eastern Maine Medical Center Brewer Maine 04412 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02115 United States Details
Dana-Farber/New Hampshire Oncology-Hematology Londonderry New Hampshire 03053 United States Details
The Ohio State University Columbus Ohio 43210 United States Details
UT Southwestern Dallas Texas 75390 United States Details
*Shaded cells indicate that there was no data available from for the field